Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section wording updated to say entries are automatically filled from PubMed. The page now shows a new Revision: v3.3.2 label.SummaryDifference0.0%

- Check28 days agoChange DetectedThe Notice About Lapse in Government Funding has been removed from the page. Previously, the notice warned that information may not be up to date due to funding status and provided operating status details.SummaryDifference0.2%

- Check42 days agoChange DetectedNo additions or deletions were detected in the page content. Core study information, eligibility criteria, outcomes, and locations appear unchanged.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old v3.1.0.SummaryDifference0.7%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no substantive content changes were detected.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.0%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.